New Bisphosphonate Inhibitors of Plant P5C Reductase
J. Agric. Food Chem., Vol. 56, No. 9, 2008 3195
General Procedure for the Preparation of Aminomethylenebispho-
sphonic Acids (1) (20)The appropriate amine (12.35 mmol), 1.35 mL
of triethyl orthoformate (1.31 g, 12.35 mmol), and 3.20 mL of diethyl
phosphite (3.41 g, 24.70 mmol) were heated for 12–16 h at 80 °C. The
reaction mixture was evaporated under reduced pressure to obtain the
corresponding crude ester that was dissolved in concentrated aqueous
hydrochloric acid and refluxed for 6 h. Then the volatile components
of the reaction mixture were evaporated under reduced pressure. The
solid residues (compounds 1a-h) were washed several times with
distilled water to obtain the pure products. The oily residues (compounds
1i,j) were crystallized from water/ethanol or water/methanol systems.
General Procedure for the Preparation of Hydroxyphosphonic Acids
(2) (21). A 1.83 mL aliquot of diethyl phosphite (1.96 g, 14.23 mmol)
was added under stirring to a mixture of magnesium oxide (1.0 g) and
the proper aromatic aldehyde (14.23 mmol) at room temperature. After
12 h dichloromethane (20 mL) was added, and the mixture was filtered
through celite. Then the solvent was evaporated under reduced pressure.
The light yellow residue was washed with distilled water to give the
pure ester, which was either refluxed for 6 h with 20% aqueous
hydrochloric acid (for compounds 2a-f) or stirred at room temperature
for 20 h with a 5-fold molar excess of bromotrimethylsilane in dry
dichloromethane (compound 2g), and then methanol was added.
Solvents were evaporated under reduced pressure. The oily residues
crystallized after 1–2 h, yielding pure solid products.
as previously described (19). A combination of ammonium sulfate
precipitation, negative chromatography at pH 7.5 on a DEAE-Sephacel
column, and anion-exchange chromatography at pH 10.0 on the same
column resulted in a 60-fold enrichment, with a 40% yield. Three
different enzyme preparations were used. The mean value for a specific
activity level in these samples was 46.2 ( 2.1 nkat mg-1. Proper checks
were done to rule out the presence in the final preparations of other
enzymes able to use the same substrates and/or further metabolize
enzyme products (i.e., P5C dehydrogenase, EC 1.5.1.12). Active
fractions were stored at 4 °C until used for biochemical determinations.
Under these conditions, P5C reductase activity was found to be stable
for at least 2 months.
Enzyme Assays. The physiological, forward reaction of P5C
reductase was measured by following the P5C-dependent oxidation of
NADH. The assay mixture contained 100 mM Tris-HCl buffer, pH
8.0, 0.1 mM MgCl2, 2 mM DL-P5C, and 0.25 mM NADH, in a final
volume of 1 mL. A limiting amount of enzyme (0.15–0.20 nkat) was
added to the prewarmed mixture, and the decrease in absorbance at
340 nm was determined at 35 °C for up to 10 min by continuous
monitoring of the sample against blanks from which P5C had been
omitted. Activity was determined from the initial linear rate, with the
assumption of an extinction coefficient of 6220 M-1 cm-1. Protein
concentration was determined by the method of Bradford (25), using
bovine serum albumin as the standard.
General Procedure for the Preparation of Aminophosphonic Acids
(3a-d) (22). A 0.72 g amount of ammonium formate (11.43 mmol)
and 2.0 g of acidic alumina were ground in a mortar until a fine,
homogeneous powder was obtained (5–10 min). Then the proper
aromatic aldehyde (11.43 mmol) was combined (solid aldehydes needed
to be ground before), and 1.50 mL of diethyl phosphite (1.58 g, 11.43
mmol) was added slowly. Following 12–16 h of vigorous stirring, the
reaction mixture was extracted with diethyl ether (250 mL). The solvent
was evaporated to dryness resulting in oily products, which were left
in a refrigerator for several days until the corresponding ester
crystallized. This was dissolved in dry dichloromethane (20 mL), and
a 5-fold molar excess of bromotrimethylsilane was added. After stirring
the mixture for 20 h at room temperature, methanol (5 mL) was added,
and 1 h later the mixture was evaporated under reduced pressure. The
oily residue crystallized after 1–2 h to give pure solid product.
General Procedure for the Preparation of Aminophosphonic Acids
(3e-i) (23). Acetamide (0.2 mol) was dissolved in acetic acid (40 mL)
and cooled in an ice bath. Then acetyl chloride (0.1 mol) was added
with cooling, and the formation of a crystalline byproduct was observed.
After 15 min the proper aldehyde (0.1 mol) was added, and the mixture
was kept for 30 min in an ice bath and left for a day at room
temperature. Then the mixture was cooled once more in an ice bath,
and phosphorus trichloride (0.1 mol) was added. The resulting mixture
was kept in the bath for 30 min, then allowed to warm to room
temperature, and finally heated for 1 h at 70–75 °C. Evaporation of
volatile components of the reaction mixture yielded an oily product,
which was refluxed for 8 h in concentrated aqueous hydrochloric acid
(100 mL). The acid was evaporated in vacuo, and the resulting product
was dissolved in ethanol (50 mL) and left until ammonium chloride
completely precipitated; then the latter was filtered off, and ethanol
was evaporated under reduced pressure. The obtained oily residue was
dissolved in ethanol (50 mL), and the aminophosphonate was precipi-
tated by the addition of pyridine and purified by recrystallization from
a water/ethanol system.
Enzyme Inhibition by Phosphonic Acids. P5C reductase inhibition
was evaluated by adding to the reaction mixture an appropriate dilution
of a 20 mM solution of a given compound, brought to pH 7.5–8.0
with KOH, so as to obtain the desired final concentration, ranging from
5 µM to 5 mM. At least three measurements were performed for each
dose. The concentrations causing 50% inhibition (IC50) of P5C reductase
activity were estimated utilizing the linear regression equation of
enzyme activity values, expressed as a percentage of untreated controls,
plotted against the logarithm of inhibitor concentration. At least three
concentrations in the rectilinear part of the resulting sigmoidal curve
were considered. Confidence limits of IC50 values were computed
according to Snedecor and Cochran (26).
In Vivo Inhibition and Reversal Experiments. To measure the
effect of some of the most active phosphonates on exponentially
growing cells, samples were withdrawn from the stock cultures in the
late exponential phase of growth and used to inoculate 100 mL culture
flasks to a density of 3.2–3.5 mg mL-1 (dry weight) in a final volume
of 25 mL. Filter-sterilized compounds (brought to pH 6.0 with KOH)
were added just after the density of the cell population reached 4.0 mg
mL-1 (dry weight). After a further 8 days of incubation, when untreated
controls reached the early stationary phase of growth, cells were
harvested by vacuum filtration, and the dry weight increase was
determined on each sample following oven drying at 90 ( 1 °C for
48 h. The same protocol was adopted for reversal experiments, where
inhibitor and amino acid supplements were added to the culture medium
simultaneously. Proline was added from a filter-sterilized 1.0 M solution.
In the case of glutamine, a freshly prepared 200 mM solution was used
to avoid spontaneous hydrolysis of the amide moiety. At least four
replicates were carried out for each treatment.
Structure–Activity Relationship Analysis. CoMFA 3D-QSAR
analysis was done within the QSAR module of Sybyl 6.9.1, Tripos
(Discovery Software, 2003), using default settings. Structures exhibiting
very low inhibitory activity (pIC50 < 1.50) were not used for
computations, as their mode of binding could be completely different
from that of highly active analogues. Additionally, another compound
that had been previously found to inhibit P5C reductase, namely, N-(3,5-
dibromo-6-methylpyridin-2-yl)aminomethylenebisphosphonic acid, was
also included in 3D-QSAR study. The structure of the most active
compound 1a was taken from the previous study (19). The other
inhibitor structures were constructed by appropriate modification of
the parent compound and minimization using the Tripos force field
and conjugate gradient minimizer. The charge for each atom in
minimized structure was computed using the MMF94 method. Mini-
mized structures were aligned by superimposition of phosphonate(s)
and aromatic ring atoms on the corresponding groups in the structure
of the lead compound 1a.
DL-P5C was synthesized by the periodate oxidation of δ-allo-
hydroxylysine and purified by cation-exchange chromatography on a
Dowex AG50 (200–400 mesh) column, as described in ref 24.
Plant Cell Culture and Growth Conditions. Suspension-cultured
cells of A. thaliana Heynh., ecotype Columbia, were grown at 24 ( 1
°C on a rotary shaker (100 rpm) under dim (<50 µmol m-2 s-1) light
in 500 mL Erlenmeyer flasks containing 130 mL of MS medium with
0.3% (w/v) sucrose and 0.5 mg L-1 of both (2,4-dichlorophenoxy)acetic
acid and 6-benzylaminopurine. Subcultures were made every 10 days
by transferring 30 mL aliquots of the suspension to 100 mL of fresh
medium.
P5C Reductase Purification. The enzyme was partially purified
from cultured cells harvested in the early stationary phase of growth,